Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Mutational Status of Driver Genes in Patients with Resected Pancreatic Ductal Adenocarcinoma is Associated with Pathological Characteristics and Overall Survival.
Campbell BA, Solinas D, Blackford AL, Dal Molin M, Purchla J, McPhaul T, Chidambaram S, Cameron JL, Lin MT, Hruban RH, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, He J. Campbell BA, et al. Ann Surg. 2025 Jun 18. doi: 10.1097/SLA.0000000000006794. Online ahead of print. Ann Surg. 2025. PMID: 40528743
Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant Chemotherapy.
Habib JR, Kinny-Köster B, Bou-Samra P, Alsaad R, Sereni E, Javed AA, Ding D, Cameron JL, Lafaro KJ, Burns WR, He J, Yu J, Wolfgang CL, Burkhart RA. Habib JR, et al. Among authors: lafaro kj. Ann Surg. 2023 Jan 1;277(1):151-158. doi: 10.1097/SLA.0000000000004915. Epub 2021 Apr 9. Ann Surg. 2023. PMID: 33843794
Ovarian Metastasis from Pancreatic Ductal Adenocarcinoma.
Habib JR, Pasha S, Khan S, Kinny-Köster B, Shoucair S, Thompson ED, Yu J, Lafaro K, Burkhart RA, Burns WR, Ronnett BM, Wolfgang CL, Hruban RH, He J, Fishman EK, Javed AA. Habib JR, et al. World J Surg. 2021 Oct;45(10):3157-3164. doi: 10.1007/s00268-021-06209-x. Epub 2021 Jul 8. World J Surg. 2021. PMID: 34236477
Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy.
Ivey GD, Shoucair S, Delitto DJ, Habib JR, Kinny-Köster B, Shubert CR, Lafaro KJ, Cameron JL, Burns WR, Burkhart RA, Thompson EL, Narang A, Zheng L, Wolfgang CL, He J. Ivey GD, et al. Among authors: lafaro kj. World J Surg. 2022 Nov;46(11):2751-2759. doi: 10.1007/s00268-022-06667-x. Epub 2022 Jul 21. World J Surg. 2022. PMID: 35861852 Free PMC article.
A Delay in Adjuvant Therapy Is Associated With Worse Prognosis Only in Patients With Transitional Circulating Tumor Cells After Resection of Pancreatic Ductal Adenocarcinoma.
Javed AA, Floortje van Oosten A, Habib JR, Hasanain A, Kinny-Köster B, Gemenetzis G, Groot VP, Ding D, Cameron JL, Lafaro KJ, Burns WR, Burkhart RA, Yu J, He J, Wolfgang CL. Javed AA, et al. Among authors: lafaro kj. Ann Surg. 2023 Jun 1;277(6):866-872. doi: 10.1097/SLA.0000000000005710. Epub 2022 Sep 15. Ann Surg. 2023. PMID: 36111839
Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma.
Kinny-Köster B, Ahmad Y, Pflüger MJ, Habib JR, Fujikura K, Hutchings D, Cameron JL, Shubert CR, Lafaro KJ, Burkhart RA, Burns WR, Javed AA, Yu J, Hruban RH, Wood LD, Thompson ED, He J. Kinny-Köster B, et al. Among authors: lafaro kj. Pancreas. 2024 Jul 1;53(6):e528-e536. doi: 10.1097/MPA.0000000000002326. Pancreas. 2024. PMID: 38888841
Patient-derived Organoid Pharmacotyping As A Predictive Tool for Therapeutic Selection in Pancreatic Ductal Adenocarcinoma.
Nicolson NG, Tandurella JA, Wu LW, Patel J, Morris E, Seppälä TT, Guinn S, Zlomke H, Shubert CR, Lafaro KJ, Burns WR, Cameron JL, He J, Fertig EJ, Jaffee EM, Zimmerman JW, Burkhart RA. Nicolson NG, et al. Among authors: lafaro kj. Ann Surg. 2024 Sep 4:10.1097/SLA.0000000000006517. doi: 10.1097/SLA.0000000000006517. Online ahead of print. Ann Surg. 2024. PMID: 39229726
Poor Prognostic Factors in Long-Term Survivors of Resected Pancreatic Ductal Adenocarcinoma: An International, Multicenter Cohort Study.
Javed AA, Rompen IF, van Goor IWJM, Stoop TF, Andel P, Mahmud O, Fatimi AS, Habib JR, Mughal NA, Schouten T, Lafaro K, Burkhart RA, Burns WR, Santvoort HCV, Dulk MD, Daams F, Mieog JSD, Stommel MWJ, Patijn GA, Hingh I, Festen S, Nijkamp MW, Klaase JM, Lips DJ, Wijsman JH, Harst EV, Manusama E, Eijck CHJV, Koerkamp BG, Kazemier G, Busch OR, Molenaar IQ, Daamen LA, He J, Wolfgang CL, Besselink MG; Dutch Pancreatic Cancer Group and the PANC-PALS Consortium. Javed AA, et al. Ann Surg. 2024 Sep 17. doi: 10.1097/SLA.0000000000006539. Online ahead of print. Ann Surg. 2024. PMID: 39286904
Implications of Neoadjuvant Therapy on Prognostic Factors in Pancreatic Ductal Adenocarcinoma: A Path Towards Personalized Prognostication.
Javed AA, Habib JR, Andel PCM, Campbell BA, Rompen IF, Mahmud O, Fatimi A, van Goor IWJM, Schouten TJ, Stoop TF, Salinas CH, van Santvoort HC, Koerkam BG, Molenaar IQ, Wolfgang CL, Besselink MG, He J, Daamen LA; Dutch Pancreatic Cancer Group and the PANC-PALS Consortium. Javed AA, et al. Ann Surg. 2025 Feb 7. doi: 10.1097/SLA.0000000000006660. Online ahead of print. Ann Surg. 2025. PMID: 39928537
93 results